Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.

Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov. Methods Mol Biol. 2019;1903:61-72 Authors: Su EW Abstract The protocol below describes an in silico method for drug repositioning (drug repurposing). The data source is ClinicalTrials.gov , which contains about a quarter of a million clinical studies. Mining such rich and clean clinical summary data could be helpful to many health-related researches. Described here is a method that utilizes serious adverse event data to identify potential new uses of drugs and dietary supplements (repositioning). PMID: 30547436 [PubMed - in process]
Source: In Silico Biol - Category: Biology Authors: Tags: Methods Mol Biol Source Type: research